Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1951 35
1952 68
1953 58
1954 66
1955 55
1956 79
1957 59
1958 55
1959 71
1960 57
1961 63
1962 36
1963 1
1964 1
1965 52
1966 110
1967 134
1968 158
1969 167
1970 195
1971 235
1972 202
1973 190
1974 201
1975 176
1976 181
1977 195
1978 200
1979 199
1980 266
1981 242
1982 253
1983 251
1984 280
1985 328
1986 276
1987 294
1988 331
1989 371
1990 374
1991 374
1992 405
1993 373
1994 425
1995 460
1996 428
1997 504
1998 617
1999 602
2000 624
2001 711
2002 735
2003 869
2004 902
2005 947
2006 987
2007 1142
2008 1243
2009 1320
2010 1446
2011 1541
2012 1663
2013 1966
2014 1986
2015 1991
2016 2006
2017 2057
2018 1883
2019 1069
2020 12
Text availability
Article attribute
Article type
Publication date

Search Results

35,314 results
Results by year
Filters applied: . Clear all
Page 1
Treat-to-Target in Inflammatory Bowel Diseases, What Is the Target and How Do We Treat?
Agrawal M and Colombel JF. Gastrointest Endosc Clin N Am 2019 - Review. PMID 31078245
Inflammatory bowel diseases, including Crohn disease (CD) and ulcerative colitis (UC), are chronic, progressive, immune-mediated inflammatory diseases of the gastrointestinal tract. ...In this review, the authors discuss the T2T guidance developed by the Selecting Therapeutic Targets in Inflammatory Bowel Disease committee, new evidence published on the role of various targets in CD and UC, as well as the real-world applicability of T2T."...
Inflammatory bowel diseases, including Crohn disease (CD) and ulcerative colitis (UC), are chronic, progressive, immune
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis.
Parian A and Limketkai BN. Curr Pharm Des 2016 - Review. PMID 26561079
Inflammatory bowel disease (IBD) including ulcerative colitis and Crohn's disease are chronic relapsing and remitting chronic diseases for which there is no cure. ...
Inflammatory bowel disease (IBD) including ulcerative colitis and Crohn's disease are chronic relapsing and remitting chronic
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of thiopurines in inflammatory bowel disease.
Bermejo F, et al. Gastroenterol Hepatol 2018 - Review. PMID 29357999
Thiopurines (azathioprine and mercaptopurine) are widely used in patients with inflammatory bowel disease. In this paper, we review the main indications for their use, as well as practical aspects on efficacy, safety and method of administration. ...Non-melanoma skin cancer, lymphomas and urinary tract tumours have been linked to thiopurine therapy. Thiopurine use is safe during conception, pregnancy and breastfeeding....
Thiopurines (azathioprine and mercaptopurine) are widely used in patients with inflammatory bowel disease. In this paper, we r …
A review of current evidence allied to step-up and top-down medication therapy in inflammatory bowel disease.
Salahudeen MS. Drugs Today (Barc) 2019. PMID 31250843
Inflammatory bowel disease (IBD), classified as a global disease in the 21st century, comprises Crohn's disease (CD) and ulcerative colitis (UC), and is manifested by chronic inflammation of the gastrointestinal tract of unknown etiology. The step-up approach is effective for inducing remission and controlling inflammation, whereas the top-down therapy appears to be a better solution for the maintenance of remission with an improved bowel function. ...
Inflammatory bowel disease (IBD), classified as a global disease in the 21st century, comprises Crohn's disease (CD) and ulcer
Review article: novel oral-targeted therapies in inflammatory bowel disease.
White JR, et al. Aliment Pharmacol Ther 2018 - Review. PMID 29672874 Free article.
BACKGROUND: There is a great unmet clinical need for efficacious, tolerable, economical and orally administrated drugs for the treatment of inflammatory bowel disease (IBD). ...METHODS: Pubmed and Medline searches were performed up to 1 March 2018 using keywords: "IBD", "UC", "CD", "inflammatory bowel disease" "ulcerative colitis", "Crohn's disease" in combination with "phase", "study", "trial" and "oral". ...
BACKGROUND: There is a great unmet clinical need for efficacious, tolerable, economical and orally administrated drugs for the treatment of …
Conventional and biological therapy for inflammatory bowel disease.
Bortlík M. Vnitr Lek 2018. PMID 30223662
Key words: biological treatment - Crohn's disease - idiopathic bowel inflammation - medication-based treat-ment - ulcerative colitis....
Key words: biological treatment - Crohn's disease - idiopathic bowel inflammation - medication-based treat-ment - ulcerative colitis. …
Probiotics in the Treatment of Inflammatory Bowel Disease.
Guandalini S and Sansotta N. Adv Exp Med Biol 2019 - Review. PMID 30632114
While considerable progress has been made in the treatment of inflammatory bowel diseases (IBD), alternative options are constantly sought by adult patients as well as frustrated parents of young patients. ...In fact, probiotics might conceivably be beneficial due to multiple mechanisms: stimulation of anti-inflammatory cytokines, inhibition of inflammatory cytokines, strengthening of intestinal barrier, and antagonistic action on pathogens. ...
While considerable progress has been made in the treatment of inflammatory bowel diseases (IBD), alternative options ar …
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Paramsothy S, et al. J Crohns Colitis 2017 - Review. PMID 28486648
BACKGROUND: Faecal microbiota transplantation [FMT] has been investigated as a potential treatment for inflammatory bowel disease [IBD]. ...
BACKGROUND: Faecal microbiota transplantation [FMT] has been investigated as a potential treatment for inflammatory bowel dise …
Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center.
Szántó K, et al. PLoS One 2018. PMID 30059523 Free PMC article.
Inflammatory bowel diseases (IBD) [Crohn's disease (CD) and ulcerative colitis (UC)], are chronic relapsing disorders of unknown etiology. The aim of this study was to determine demographic features, disease phenotypes, medical and surgical therapies in our IBD patients and to identify which parameters are in association with the need of surgery and/or biologic therapy. ...
Inflammatory bowel diseases (IBD) [Crohn's disease (CD) and ulcerative colitis (UC)], are chronic relapsing disorders o
35,314 results
Jump to page
Feedback